Sildenafils effectiveness in the primary coronary slow flow phenomenon: a pilot randomised controlled clinical trial
Open Heart
AUGUST 25, 2024
Background On the one hand, the primary coronary slow flow phenomenon (CSFP) can cause recurrence of chest pain, prompting medical examinations and further healthcare costs, while on the other hand, it can lead to myocardial infarction, ventricular arrhythmia and sudden cardiac death.
Let's personalize your content